Skip to main content

LEVETIRACETAM solution

NDC 62135-548 · Chartwell RX, LLC

Generic nameLEVETIRACETAM
Dosage formSOLUTION
RouteORAL
Active ingredient(s)LEVETIRACETAM
Strength100 mg/mL
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

62135-548-47 — 473 mL in 1 BOTTLE (62135-548-47)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55154-5782 — LEVETIRACETAM, 58657-860 — levetiracetam, 60429-349 — Levetiracetam, 60429-350 — Levetiracetam, 60505-3280 — Levetiracetam, 60505-3517 — Levetiracetam, 60505-3518 — Levetiracetam, 60687-249 — Levetiracetam, 60687-657 — Levetiracetam, 60687-668 — Levetiracetam, 63187-360 — Levetiracetam, 63323-400 — LEVETIRACETAM, 63629-4137 — Levetiracetam, 63629-4675 — Levetiracetam, 63629-7516 — Levetiracetam, 63629-8315 — Levetiracetam, 63629-9615 — Levetiracetam, 63629-9847 — LEVETIRACETAM, 64980-604 — Levetiracetam, 64980-605 — Levetiracetam, +277 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources